Haroun Gajraj/LinkedIn
Nov 15, 2025, 15:42
Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, reposted from Enric Roche, on LinkedIn:
“Thank you, Enric Roche, MD, PhD, for a very nice demonstration of the piston effect in foam sclerotherapy.”
Quoting Enric Roche’s post:
“This is what we call the piston effect in foam sclerotherapy. The foam uniformly displaces the blood, maintaining its structure and promoting contact between the sclerosant and the endothelium. To optimise this effect in all concentrations and drugs is always an advantage to get better outcomes. This behaviour occurs with dry foams due to their greater stability.
This is a 0.2% Polidocanol foam.”

Stay informed with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
